Form D · Pharmaceuticals
Spiral Therapeutics Inc
South San Francisco, CA · CIK 0001761906
Offering snapshot reported Apr 16, 2026 · SEC filing
- Reported sold
- $27.1M Offering amount: $27.1M
- Investors reported
- 34 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 16, 2026 | Initial | $27,089,839 | No comparison | 34 | SEC filing |
| Feb 7, 2023 | Amendment | $10,904,985 | $9,639,642vs Dec 2, 2022 | 48 | SEC filing |
| Dec 2, 2022 | Initial | $1,265,343 | No comparison | 12 | SEC filing |
| Dec 19, 2018 | Initial | $8,474,654 | No comparison | 38 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-580745
Total Offering Amount includes conversion of outstanding indebtedness in the amount of $12,089,841.65.
Source: Form D, filed Apr 16, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anthony Adamis | Director |
| Eugene De Juan | Director, Executive |
| Lawrence Fritz | Director |
| Guy Jean Savoir Garcia | Director |
| Frederic Guerard | Director |
| Angela Macfarlane | Director |
| Guy Nohra | Director |
| Guy P. Nohra | Director |
| Jean Frederic Paulsen | Director |
| Hugo Peris | Director, Executive |
| Guy Jean Savoir Garcia | Director |
| Warren Thaler | Director |
| Diamantis Xylas | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6000 Shoreline Court Suite 206
South San Francisco, CA, 94080
Phone: 650-453-0893
South San Francisco, CA, 94080
Phone: 650-453-0893